<DOC>
	<DOCNO>NCT02940860</DOCNO>
	<brief_summary>Evaluation safety efficacy iron isomaltoside compare iron sucrose subject IDA NDD-CKD .</brief_summary>
	<brief_title>Iron Isomaltoside Iron Sucrose Treatment Iron Deficiency Anemia Non-Dialysis-Dependent Chronic Kidney Disease</brief_title>
	<detailed_description>Iron deficiency anaemia ( IDA ) common problem associate many chronic disease chronic kidney disease ( CKD ) . IDA substantial medical quality life ( QoL ) burden subject , treatment subject include treatment underlie cause restoration haemoglobin ( Hb ) concentration iron store . This study plan evaluate safety efficacy iron isomaltoside compare iron sucrose subject IDA NDD-CKD .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Deficiency Diseases</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferric oxide , saccharated</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>Inclusion Criteria include : 1 . Men woman ≥ 18 year 2 . Hb ≤ 10 g/dL 3 . Chronic renal impairment , define either ( ) eGFR &lt; 60 mL/min/1.73m2 screening ( calculated modification diet renal disease ( MDRD ) ) , ( ii ) eGFR &lt; 90 mL/min/1.73m2 screen kidney damage indicate abnormality urine composition per medical history and/or intermediate/high risk cardiovascular disease base Framingham model 4 . Screening sferritin ≤ 100 ng/mL , ≤ 300 ng/mL TSAT ≤ 30 % 5 . Either ESAs ESAs stable dose 4 week randomisation 6 . Willingness participate signing informed consent form Exclusion Criteria include : 1 . Anaemia predominantly cause factor IDA 2 . Hemochromatosis iron storage disorder 3 . Previous serious hypersensitivity reaction IV iron compound 4 . Prior screen trial period ; treat red blood cell transfusion , radiotherapy , and/or chemotherapy 5 . Undergoing dialysis treatment CKD 6 . Planned surgical procedure within trial period 7 . Decompensated liver cirrhosis active hepatitis 8 . Alcohol drug abuse within past 6 month . 9 . Pregnant nursing woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>